🇺🇸 FDA
Patent

US 9758831

Methods of predicting clinical course and treating multiple sclerosis

granted A61PA61P25/00

Quick answer

US patent 9758831 (Methods of predicting clinical course and treating multiple sclerosis) held by TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
Grant date
Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61P, A61P25/00